The Ability of Baroreflex Activation to Improve Blood Pressure and Resistance Vessel Function in Spontaneously Hypertensive Rats is Dependent on Stimulation Parameters

Overview

Journal Hypertens Res

Specialty Cardiology & Vascular Diseases

Date 2021 Mar 12

PMID 33707760

Citations 6

Authors

Gean Domingos-Souza

Fernanda Machado Santos-Almeida

Cesar Arruda Meschiari

Nathanne S Ferreira

Camila A Pereira

Nayara Pestana-Oliveira

Thais Caroline Prates-Costa

Rita C Tostes

Carl White

Rubens Fazan Jr

Affiliations

Soon will be listed here.

Abstract

Baroreflex activation by electric stimulation of the carotid sinus (CS) effectively lowers blood pressure. However, the degree to which differences between stimulation protocols impinge on cardiovascular outcomes has not been defined. To address this, we examined the effects of short- and long-duration (SD and LD) CS stimulation on hemodynamic and vascular function in spontaneously hypertensive rats (SHRs). We fit animals with miniature electrical stimulators coupled to electrodes positioned around the left CS nerve that delivered intermittent 5/25 s ON/OFF (SD) or 20/20 s ON/OFF (LD) square pulses (1 ms, 3 V, 30 Hz) continuously applied for 48 h in conscious animals. A sham-operated control group was also studied. We measured mean arterial pressure (MAP), systolic blood pressure variability (SBPV), heart rate (HR), and heart rate variability (HRV) for 60 min before stimulation, 24 h into the protocol, and 60 min after stimulation had stopped. SD stimulation reversibly lowered MAP and HR during stimulation. LD stimulation evoked a decrease in MAP that was sustained even after stimulation was stopped. Neither SD nor LD had any effect on SBPV or HRV when recorded after stimulation, indicating no adaptation in autonomic activity. Both the contractile response to phenylephrine and the relaxation response to acetylcholine were increased in mesenteric resistance vessels isolated from LD-stimulated rats only. In conclusion, the ability of baroreflex activation to modulate hemodynamics and induce lasting vascular adaptation is critically dependent on the electrical parameters and duration of CS stimulation.

Citing Articles

Advances on the Experimental Research in Resistant Hypertension.

Irigoyen M, Fetter C, De Angelis K Curr Hypertens Rep. 2024; 26(12):475-482.

PMID: 39023702 DOI: 10.1007/s11906-024-01315-2.

DNA demethylation in the hypothalamus promotes transcription of Agtr1a and Slc12a2 and hypertension development.

Ghosh K, Zhou J, Shao J, Chen S, Pan H J Biol Chem. 2023; 300(2):105597.

PMID: 38160798 PMC: 10830874. DOI: 10.1016/j.jbc.2023.105597.

Key challenges in exploring the rat as a preclinical neurostimulation model for aortic baroreflex modulation in hypertension.

Salman I Hypertens Res. 2023; 47(2):399-415.

PMID: 37919429 DOI: 10.1038/s41440-023-01486-6.

Low intensity stimulation of aortic baroreceptor afferent fibers as a potential therapeutic alternative for hypertension treatment.

Salman I, Ameer O, McMurray S, Hassan S, Sridhar A, Lewis S Sci Rep. 2022; 12(1):12242.

PMID: 35851099 PMC: 9293925. DOI: 10.1038/s41598-022-15761-y.

Update on Hypertension Research in 2021.

Mogi M, Maruhashi T, Higashi Y, Masuda T, Nagata D, Nagai M Hypertens Res. 2022; 45(8):1276-1297.

PMID: 35790879 PMC: 9255494. DOI: 10.1038/s41440-022-00967-4.

References

Seravalle G, DellOro R, Grassi G . Baroreflex activation therapy systems: current status and future prospects. Expert Rev Med Devices. 2019; 16(12):1025-1033. DOI: 10.1080/17434440.2019.1697230. View

Bisognano J, Bakris G, Nadim M, Sanchez L, Kroon A, Schafer J . Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial. J Am Coll Cardiol. 2011; 58(7):765-73. DOI: 10.1016/j.jacc.2011.06.008. View

Illig K, Levy M, Sanchez L, Trachiotis G, Shanley C, Irwin E . An implantable carotid sinus stimulator for drug-resistant hypertension: surgical technique and short-term outcome from the multicenter phase II Rheos feasibility trial. J Vasc Surg. 2006; 44(6):1213-1218. DOI: 10.1016/j.jvs.2006.08.024. View

de Leeuw P, Alnima T, Lovett E, Sica D, Bisognano J, Haller H . Bilateral or unilateral stimulation for baroreflex activation therapy. Hypertension. 2014; 65(1):187-92. DOI: 10.1161/HYPERTENSIONAHA.114.04492. View

Tordoir J, Scheffers I, Schmidli J, Savolainen H, Liebeskind U, Hansky B . An implantable carotid sinus baroreflex activating system: surgical technique and short-term outcome from a multi-center feasibility trial for the treatment of resistant hypertension. Eur J Vasc Endovasc Surg. 2007; 33(4):414-21. DOI: 10.1016/j.ejvs.2006.11.025. View

Wustmann K, Kucera J, Scheffers I, Mohaupt M, Kroon A, de Leeuw P . Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension. Hypertension. 2009; 54(3):530-6. DOI: 10.1161/HYPERTENSIONAHA.109.134023. View

Abraham W, Zile M, Weaver F, Butter C, Ducharme A, Halbach M . Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction. JACC Heart Fail. 2015; 3(6):487-496. DOI: 10.1016/j.jchf.2015.02.006. View

Gronda E, Seravalle G, Brambilla G, Costantino G, Casini A, Alsheraei A . Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study. Eur J Heart Fail. 2014; 16(9):977-83. PMC: 4237551. DOI: 10.1002/ejhf.138. View

Alnima T, Scheffers I, de Leeuw P, Winkens B, Jongen-Vancraybex H, Tordoir J . Sustained acute voltage-dependent blood pressure decrease with prolonged carotid baroreflex activation in therapy-resistant hypertension. J Hypertens. 2012; 30(8):1665-70. DOI: 10.1097/HJH.0b013e3283551f10. View

10.

Heusser K, Tank J, Engeli S, Diedrich A, Menne J, Eckert S . Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension. 2010; 55(3):619-26. DOI: 10.1161/HYPERTENSIONAHA.109.140665. View

11.

Mancia G, Grassi G . The autonomic nervous system and hypertension. Circ Res. 2014; 114(11):1804-14. DOI: 10.1161/CIRCRESAHA.114.302524. View

12.

Yoruk A, Bisognano J, Gassler J . Baroreceptor Stimulation for Resistant Hypertension. Am J Hypertens. 2016; 29(12):1319-1324. DOI: 10.1093/ajh/hpw074. View

13.

Lohmeier T, Irwin E, Rossing M, Serdar D, Kieval R . Prolonged activation of the baroreflex produces sustained hypotension. Hypertension. 2004; 43(2):306-11. DOI: 10.1161/01.HYP.0000111837.73693.9b. View

14.

Lohmeier T, Dwyer T, Hildebrandt D, Irwin E, Rossing M, Serdar D . Influence of prolonged baroreflex activation on arterial pressure in angiotensin hypertension. Hypertension. 2005; 46(5):1194-200. DOI: 10.1161/01.HYP.0000187011.44201.2e. View

15.

Lohmeier T, Hildebrandt D, Dwyer T, Iliescu R, Irwin E, Cates A . Prolonged activation of the baroreflex decreases arterial pressure even during chronic adrenergic blockade. Hypertension. 2009; 53(5):833-8. PMC: 2698596. DOI: 10.1161/HYPERTENSIONAHA.109.128884. View

16.

Lohmeier T, Hildebrandt D, Dwyer T, Barrett A, Irwin E, Rossing M . Renal denervation does not abolish sustained baroreflex-mediated reductions in arterial pressure. Hypertension. 2006; 49(2):373-9. DOI: 10.1161/01.HYP.0000253507.56499.bb. View

17.

Lohmeier T, Iliescu R . Chronic lowering of blood pressure by carotid baroreflex activation: mechanisms and potential for hypertension therapy. Hypertension. 2011; 57(5):880-6. PMC: 3085950. DOI: 10.1161/HYPERTENSIONAHA.108.119859. View

18.

JUDY W, Watanabe A, Murphy W, Aprison B, Yu P . Sympathetic nerve activity and blood pressure in normotensive backcross rats genetically related to the spontaneously hypertensive rat. Hypertension. 1979; 1(6):598-604. DOI: 10.1161/01.hyp.1.6.598. View

19.

Yamori Y, Okamoto K . Hypothalamic tonic regulation of blood pressure in spontaneously hypertensive rats. Jpn Circ J. 1969; 33(5):509-19. DOI: 10.1253/jcj.33.509. View

20.

Courand P, Feugier P, Workineh S, Harbaoui B, Bricca G, Lantelme P . Baroreceptor stimulation for resistant hypertension: first implantation in France and literature review. Arch Cardiovasc Dis. 2014; 107(12):690-6. DOI: 10.1016/j.acvd.2014.08.002. View